MED MediClin AG

DGAP-News: MediClin AG: The Board of Management of MEDICLIN will be expanded - Dr. York Dhein will join on April 1st, 2021

DGAP-News: MediClin AG / Key word(s): Personnel
MediClin AG: The Board of Management of MEDICLIN will be expanded - Dr. York Dhein will join on April 1st, 2021

12.01.2021 / 14:00
The issuer is solely responsible for the content of this announcement.


Offenburg, January 12, 2021

The Board of Management of MEDICLIN will be expanded -
Dr. York Dhein will join on April 1st, 2021

In its meeting on January 11, 2021, the Supervisory Board of MEDICLIN Aktiengesellschaft appointed Dr. med. York Dhein as additional member to the Management Board of MEDICLIN AG.

The 54-year-old is a specialist in internal medicine and, after working in a clinic, worked for a large company health insurance fund for several years, last as head of care and contract management. This was followed by five years as a consultant in the health care business of an international management consulting company. Since 2013 he has been a member of the board and later chairman of the board of Johannesbad Holding SE & Co. KG, a family-run group of companies with a clear profile as a health service provider with a focus on rehabilitation.

York Dhein stands up for a stronger position of rehabilitation in the health sector for years. He has an excellent branch network and is involved in the board of the VPKA (Association of Private Hospitals) Bavaria.

The Management Board welcomes the reinforcement in the top management of MEDICLIN. The demands on the health system will increase significantly in the future, and with it the challenges in the largest segment of MEDICLIN, the post-acute segment.

About MEDICLIN AG (Ticker: MED; WKN: 659 510)

MEDICLIN has around 8,500 beds / care places and employs about 10,500 people. In a strong network, MEDICLIN offers the patient integrative care from the first visit to the doctor through the operation and the subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual and personal needs.

MEDICLIN - A company of the Asklepios Group.



12.01.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail:
Internet:
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1160059

 
End of News DGAP News Service

1160059  12.01.2021 

fncls.ssp?fn=show_t_gif&application_id=1160059&application_name=news&site_id=research_pool
EN
12/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MediClin AG

 PRESS RELEASE

EQS-News: MEDICLIN ends successful 2024 financial year

EQS-News: MEDICLIN AG / Key word(s): Annual Report/Miscellaneous MEDICLIN ends successful 2024 financial year 28.03.2025 / 10:24 CET/CEST The issuer is solely responsible for the content of this announcement. Offenburg, March 28, 2025 MEDICLIN ends successful 2024 financial year   MEDICLIN Aktiengesellschaft (ticker: MED; WKN 659 510) today published its annual report for the year 2024. The group generated sales of EUR 748.8 mill., which corresponds to an increase of 2.6 % compared to the previous year (2023: EUR 730.1 mill.). MEDICLIN the highest sales in thus achieved...

 PRESS RELEASE

EQS-News: MEDICLIN beendet erfolgreiches Geschäftsjahr 2024

EQS-News: MEDICLIN AG / Schlagwort(e): Jahresbericht/Sonstiges MEDICLIN beendet erfolgreiches Geschäftsjahr 2024 28.03.2025 / 10:24 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Offenburg, 28. März 2025 MEDICLIN beendet erfolgreiches Geschäftsjahr 2024                                                                               Die MEDICLIN Aktiengesellschaft (Ticker: MED; WKN 659 510) hat heute ihren Geschäftsbericht für das Jahr 2024 veröffentlicht. Der Konzern erzielte einen Umsatz von 748,8 Mio. Euro, was einer Steigerung vo...

 PRESS RELEASE

EQS-News: MEDICLIN lädt zur virtuellen Bilanzpressekonferenz 2025 ein

EQS-News: MEDICLIN AG / Schlagwort(e): Konferenz/Sonstiges MEDICLIN lädt zur virtuellen Bilanzpressekonferenz 2025 ein 19.03.2025 / 15:18 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Offenburg, 19. März 2025 MEDICLIN lädt zur virtuellen Bilanzpressekonferenz 2025 ein Die MEDICLIN Aktiengesellschaft (Ticker: MED; WKN 659 510) lädt zur virtuellen Bilanzpressekonferenz 2025 ein. Diese wird am28. März 2025 um 11.00 Uhr (MEZ) stattfinden. Der Vorstand der MEDICLIN wird im Rahmen eines Webcasts über das Geschäftsjahr 2024, die aktuelle...

 PRESS RELEASE

EQS-News: MEDICLIN invites you to the 2025 virtual press conference o...

EQS-News: MEDICLIN AG / Key word(s): Conference/Miscellaneous MEDICLIN invites you to the 2025 virtual press conference on the financial statements for the year 2024 19.03.2025 / 15:18 CET/CEST The issuer is solely responsible for the content of this announcement. Offenburg, March 19, 2024 MEDICLIN invites you to the 2025 virtual press conference on the financial statements for the year 2024 MEDICLIN (Ticker: MED; WKN 659 510) invites you to the 2025 virtual press conference on the financial statements for the year 2024. The event will take place on March 28, 2025 at 1...

 PRESS RELEASE

EQS-News: MEDICLIN presents preliminary figures for the 2024 financial...

EQS-News: MEDICLIN AG / Key word(s): Preliminary Results MEDICLIN presents preliminary figures for the 2024 financial year 27.02.2025 / 13:03 CET/CEST The issuer is solely responsible for the content of this announcement. Offenburg, February 27, 2024 MEDICLIN presents preliminary figures for the 2024 financial year MEDICLIN increases its group sales in 2024 by 2.6% to EUR 748.8 mill. Group operating result reaches EUR 53.5 mill. (previous year: EUR 12.7 mill.) Capacity utilisation in the post-acute segment above 86% in every quarter MEDICLIN generated group sales of ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch